Dominique Fontanilla (@Datamonitor_DF) header
Dominique Fontanilla (@Datamonitor_DF) profile picture

@Datamonitor_HC. Views expressed are my own

Joined January 2014
Photo by Dominique Fontanilla (@Datamonitor_DF)Photo by Dominique Fontanilla (@Datamonitor_DF)Photo by Dominique Fontanilla (@Datamonitor_DF)Photo by Dominique Fontanilla (@Datamonitor_DF)Photo by Dominique Fontanilla (@Datamonitor_DF)
Patents And LOEs Poised To Be Hot Q2 Topics bit.ly/46QVRFa #PharmaScrip
1
231
Acadia’s Launch Of Daybue Astonishes Analysts bit.ly/3D9T2lb #PharmaScrip
1
251
Dominique Fontanilla retweeted
Do you work with #CDMO partnerships when it comes to #drugdevelopment? What are the challenges or opportunities have you encountered? Tell us your thoughts in this short survey https://teapawt.org/t.co/pKlgr6pOWz
1
1
Dominique Fontanilla retweeted
Did you see our winner of the Lifetime Achievment Award at the 2020 #ScripAwards? Dame Sally Davies had this to say: "I've never been prouder to be part of an industry that innovates and collaborates." Be part of the 2021 #ScripAwards & Enter today https://teapawt.org/t.co/y4N0So10GS
Dominique Fontanilla retweeted
$BMY declares deucravacitinib as first in new TYK2-selective class to differentiate from JAKs #AADVMX2021 s21.q4cdn.com/104148044/file…
1
1
Diagnostics Saves Roche From Q1 Losses https://teapawt.org/t.co/mSdQQ2tztW
Dominique Fontanilla retweeted
Just a few more hours until #IQVIA discuss the modern #RegulatoryOperations process and how current & future technologies there are to support the adoption of new standards. Have you registered yet? https://teapawt.org/t.co/E1CIsPJKlm
Dominique Fontanilla retweeted
Get the perspective of #CDMO partnerships from 3 different #pharma companies in this summary report from #Cambrex. Download your copy today https://teapawt.org/t.co/zZXbHEXGdn
Dominique Fontanilla retweeted
The 2021 #CitelineAwards are designed to champion excellence across the spectrum of key R&D activities. The deadline for entries is the 16th July 2021. Enter now and be recognised for your work! https://teapawt.org/t.co/m7Z3YjmcC0
Dominique Fontanilla retweeted
Publishing has been a core comptency of #Regulatory Operations & has evolved in many ways since paper publishing was first introduced. Join us on Thursday as we discuss the modern process & the future trends. Register today https://teapawt.org/t.co/A5D8DKAkx8
Dominique Fontanilla retweeted
What do you look for when partnering with a #CDMO? Is it a cultural fit? Capacity? Or is it technical expertise? Find out more about #CDMO partnerships in this report from #Cambrex https://teapawt.org/t.co/BzUfVhQcVw
Dominique Fontanilla retweeted
Calling #PinkSheet Subscribers! Are you putting your organization at risk for non-compliance for your #clinicaltrials. Sign up to receive a free assessment from #TrialScopeDisclose here https://teapawt.org/t.co/v6SZfOieml Offer ends April 28th 2021
Dominique Fontanilla retweeted
Learn how #CitelineConnect supported the fastest-recruiting #covid19 #clinicaltrial in operation Warp Speed history. Watch this insightful #webinar-on-demand here https://teapawt.org/t.co/BJmahqasUl
Exec Chat: CHF Solutions Focused On Expanding Access To Aquadex Ultrafiltration https://teapawt.org/t.co/ZOBrr4UNQh
US FDA Panel Grapples With Dermal Filler Adverse Events https://teapawt.org/t.co/kghFxmbowk
Slaoui Apologizes For Sexual Harassment, Loses Further Industry Roles https://teapawt.org/t.co/5viCrJS0oN #PharmaScrip
Dominique Fontanilla retweeted
#Pharma industry leaders, R&D analysts & innovators will gather virtually on April 20th & 22nd, to discuss the state of play in the world of #PharmaRnD. Register here https://teapawt.org/t.co/08HkPNuk7w
Dominique Fontanilla retweeted
Will you be joining us next week as we discuss the predictions & trends for when #clinicaltrials return to 'normal'. Register your space here & join us next Tuesday at 10am ET. https://teapawt.org/t.co/JlFsTYNDqs
Dominique Fontanilla retweeted
Don't forget to register for our #webinar with #STAPharmaceuticals. Tomorrow at 11am ET, we will be discussing real cases where unexpected concerns from #regulatory reviewers impacted program launch. Register your spot here https://teapawt.org/t.co/Tk1G9sOnby
1
1
Dominique Fontanilla retweeted
What are the opportunities & challenges when it comes to end-to-end #drug development partnerships? Download this summary report from #Cambrex here https://teapawt.org/t.co/JZDBpo5FOM